Search Results

You are looking at 331 - 340 of 1,450 items for :

  • "characteristics" x
  • Refine by Access: All x
Clear All
Full access

characteristics and overall treatment patterns of patients diagnosed with mNETs from a retrospective database analysis of community oncology practices. This report provides additional information on the treatment outcomes for this population. Methods: Clinical

Full access

Sriram Yennurajalingam, Vicente Valero, Zhanni Lu, Diane D. Liu, Naifa L. Busaidy, James M. Reuben, Carolina Diaz Fleming, Janet L. Williams, Kenneth R. Hess, Karen Basen-Engquist, and Eduardo Bruera

interventions, along with tolerability. To compare patient characteristics, we used the chi-square and the Wilcoxon signed rank tests for the FACIT-F (primary outcome), ESAS fatigue item, PROMIS-F, MFSI-SF, ESAS physical distress score, ESAS psychological

Full access

P. Connor Johnson, Netana H. Markovitz, Tamryn F. Gray, Sunil Bhatt, Ryan D. Nipp, Nneka Ufere, Julia Rice, Matthew J. Reynolds, Mitchell W. Lavoie, Carlisle E.W. Topping, Madison A. Clay, Charlotta Lindvall, and Areej El-Jawahri

characteristics along with healthcare utilization and mortality. To investigate the relationship between social support and OS, we conducted Cox proportional hazards regression analyses, adjusting for the following covariates that were a priori defined based on

Full access

Tejaswi Mudigonda, Daniel J. Pearce, Brad A. Yentzer, Phillip Williford, and Steven R. Feldman

physicians, and $521 for other physicians. 28 Table 2 Treatment Characteristics of Non–Melanoma Skin Cancer Episodes in 1999–2000 by Specialty To further illustrate treatment characteristics according to specialty, Manternach et al. 27

Full access

Mei-Chin Hsieh, Lu Zhang, Xiao-Cheng Wu, Mary B. Davidson, Michelle Loch, and Vivien W. Chen

’ sociodemographic and tumor characteristics, and to examine the impact of guideline-concordant treatment status and cancer subtype on survival outcome. Methods Data Source and Study Cohort Data on female breast cancer were obtained from the Louisiana Tumor Registry

Full access

Katy E. Balazy, Cecil M. Benitez, Paulina M. Gutkin, Clare E. Jacobson, Rie von Eyben, and Kathleen C. Horst

treatments, and there was no difference between NES and ES patients ( P =.794). Table 1. Baseline Patient Characteristics Of the 5 time intervals analyzed, the longest interval was from resection to start of RT (mean [SD], 2.8 [1.8] months), and

Full access

Eric D. Miller, Ansel P. Nalin, Dayssy A. Diaz Pardo, Andrea L. Arnett, Emily Huang, Alessandra C. Gasior, Pannaga Malalur, Hui-Zi Chen, Terence M. Williams, and Jose G. Bazan

account for clustering in matched pairs. All statistical analyses were performed using SAS 9.4 (SAS Institute Inc). Results Baseline Characteristics We identified 9,156 elderly patients and 17,640 nonelderly patients who met the study criteria

Full access

Tammy T. Hshieh, Clark DuMontier, Timothy Jaung, Nupur E. Bahl, Chelsea E. Hawley, Lee Mozessohn, Richard M. Stone, Robert J. Soiffer, Jane A. Driver, and Gregory A. Abel

on information extracted from the oncology consultation note. Statistical Analysis Population characteristics were summarized using proportions. Chi-square analyses were performed in the total population to assess for associations between

Full access

Characteristics (N=35) Conclusions: Interim results show high pCR rates compared with those reported with anthracyclines/taxanes in TNBC. Pretreatment biopsies will be analyzed for predictive markers. An ongoing randomized study is evaluating the

Full access

Stephanie Alimena, Suvidya Lakshmi Pachigolla, Sarah Feldman, David Yang, Peter F. Orio III, Larissa Lee, and Martin King

not if aged ≥65 years (11.7% vs 12.4%; P =.43). Figure 1 shows differences in private insurance, stage I disease, and optimal treatment among Black versus non-Black patients by age. Table 1. Demographic and Treatment Characteristics of the Study